Аннотация:Chronic inflammatory
demyelinating polyneuropathy (CIDP) is characterized by a
progressive or relapsing course of the disease, leading to
temporal or permanent disability and requiring maintenance
of long-term immunotherapy. We assessed clinical and
paraclinical outcomes in patients with CIDP history of more
than 5 years.